IMPACTIVE will study the synthesis of three families of active pharmaceutical ingredients, and develop pilot production process ready for scale up. (IMAGE)

Agata Comunicación Científica SL

IMPACTIVE will study the synthesis of three families of active pharmaceutical ingredients, and develop pilot production process ready for scale up.

Caption

A hand holds several medical pills. On top with key leaders in the field from academia and industry, Impactive counts on two partners in the pharmaceutical industry – Novartis and Merck.

Credit

Impactive

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.